Clinical Trials Browser

Interventional × Hormone Receptor Positive Malignant Neoplasm of Breast × Everolimus × Clear all

NCT02025712 2014-01-01

Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer

Phase 2 Unknown

BreastOther neoplasm

Hormone Receptor Positive Malignant Neoplasm of Breast